| A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults (NCT07697846) | Beijing QL Biopharmaceutical Co.,Ltd | 2026-07-18 |
| Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants (NCT07550816) | Beijing QL Biopharmaceutical Co.,Ltd | 2026-05-27 |
| A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants (NCT07443059) | Beijing QL Biopharmaceutical Co.,Ltd | 2026-04-13 |
| A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1) (NCT07230119) | Beijing QL Biopharmaceutical Co.,Ltd | 2026-01-16 |
| Efficacy and Safety of ZT006 in Overweight and Obese Participants (NCT07230132) | Beijing QL Biopharmaceutical Co.,Ltd | 2025-12-12 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers (NCT07184502) | Beijing QL Biopharmaceutical Co.,Ltd | 2025-10-16 |
| Dose-escalation and Food Effect Study of ZT006 in Healthy, Overweight and Obese Participants (NCT07307638) | Beijing QL Biopharmaceutical Co.,Ltd | 2024-11-28 |
| A Study of ZT002 Injection With Subjects With Overweight or Obesity (NCT07020884) | Beijing QL Biopharmaceutical Co.,Ltd | 2024-08-14 |
| A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT07065032) | Beijing QL Biopharmaceutical Co.,Ltd | 2024-02-19 |
| A Study of ZT002 Injection in Participants With Overweight or Obesity (NCT06371326) | Beijing QL Biopharmaceutical Co.,Ltd | 2023-11-21 |
| A SAD Study of ZT002 Injection in Healthy Participants (NCT06423872) | Beijing QL Biopharmaceutical Co.,Ltd | 2023-06-19 |